Basilio Flávia Machado Alves, Mulinari-Brenner Fabiane, Werner Betina, de Macedo Nubia Vedovatto
Dermatology Division - Hospital de Clínicas, Federal University of Paraná, Curitiba, 80710-240, Paraná, Brazil.
Pathology Department - Hospital de Clínicas, Federal University of Paraná, Curitiba, Brazil.
Arch Dermatol Res. 2025 May 6;317(1):750. doi: 10.1007/s00403-025-04247-2.
Microinfusion is a superficial microneedling procedure that infuses medications into the surface of the dermis through disposable needles attached to tattoo equipment. Various medications can be microinfused; minoxidil is frequently utilized as an adjuvant treatment for androgenetic alopecia, but little data is available on its systemic effects when administered via this technique.
To compare blood pressure readings before and after microinfusion of minoxidil in the scalp to assess this drug's systemic effects when applied using this technique.
This randomized, controlled, blinded study was conducted with 24 patients divided into 2 groups to compare microinfusion with 0.5% minoxidil and saline solution (control group). Participants underwent 3 sessions at monthly intervals, and their blood pressure was measured before and after each microinfusion procedure.
A statistically significant reduction in diastolic blood pressure was observed after the procedure in the minoxidil group (p = 0.037). In the control group, a statistically significant increase in systolic blood pressure was found (p = 0.013).
Reduction of diastolic blood pressure in the minoxidil group proved dermal delivery and systemic absorption of the medication after scalp microinfusion. Increased systolic pressure in the control group may be related to pain during the procedure. BRAZILIAN REGISTRY OF CLINICAL TRIALS: (ReBEC): RBR-368fdb3; Date of registration: April, 11th, 2024 (retrospectively registered).
微针注射是一种浅表微针治疗方法,通过连接纹身设备的一次性针头将药物注入真皮表面。可以微针注射多种药物;米诺地尔经常被用作雄激素性脱发的辅助治疗药物,但关于通过这种技术给药时其全身作用的数据很少。
比较头皮微针注射米诺地尔前后的血压读数,以评估使用该技术应用此药物时的全身作用。
这项随机、对照、双盲研究对24名患者进行,分为2组,比较0.5%米诺地尔微针注射与生理盐水(对照组)。参与者每月接受3次治疗,每次微针注射前后测量血压。
米诺地尔组治疗后舒张压有统计学意义的降低(p = 0.037)。在对照组中,收缩压有统计学意义的升高(p = 0.013)。
米诺地尔组舒张压降低证明了头皮微针注射后药物的经皮递送和全身吸收。对照组收缩压升高可能与治疗过程中的疼痛有关。巴西临床试验注册中心(ReBEC):RBR - 368fdb3;注册日期:2024年4月11日(追溯注册)。